February 2004
The Harvard Health Caucus at Harvard Medical School is no longer functioning as a student organization. We hope the resources on this website, including links, videos and background on our past activities, will be helpful to you in your research.
|
11 February 2004
The Significance of Vaccines in Global Health
 Click here to read about the event
Introduction - Vaccines: Reexamining the Proven Armamentarium
Wolfgang Klietmann, M.D., Lecturer on Pathology, Harvard Medical School
Keynote - The Significance of Vaccines in Global Health Raymond V. Gilmartin, President & CEO, Merck & Co., Inc.
Panel Discussion
Raymond V. Gilmartin, President & CEO, Merck & Co., Inc. Adel Mahmoud, M.D., Ph.D., President, Merck Vaccine Division Wolfgang Klietmann, M.D., MS, Harvard Business School Health Industry Alumni Association
Moderator: Raj Shah, M.D., Deputy Director, Policy & Finance, Bill and Melinda Gates Foundation
The Wall Street Journal recently identified some of the challenges facing the vaccine industry, and society: The malfunctioning of the small but vital marketplace for vaccines in America; product liability lawsuits impeding vaccine development and shrinking profit margins have driven many producers out of this indispensable business; and the government exercise of monopsony power in the vaccine market. We need a vital vaccine industry in collaboration with a well functioning reorganized Public Health System to contain menacing scourges and to keep contagion in check.
The organizers of this event gratefully acknowledge the support of Boston Private Bank.
This event was co-sponsored by, HARVARD BUSINESS SCHOOL HEALTH INDUSTRY ALUMNI ASSOCIATION and the HARVARD HEALTH CAUCUS AT HARVARD MEDICAL SCHOOL
|
|
________________________________________________
In 2002-2003, the Harvard Health Caucus at Harvard Medical School sponsored a University-wide essay contest addressing the following topic:
What is the greatest challenge to the U.S. health care system today?
Student submissions, which came from students at Harvard Business School, the Harvard Graduate School of Arts and Sciences, Harvard Law School and Harvard College reflected a variety of perspectives and showed how different academic and research fields address issues related to health care and health policy. Members of the Essay Contest Planning Committee previewed the submissions and sent them on to three experts in the field of health and health policy for review. Thanks to the thoughtful work of Dr. Jeffrey Drazen (Editor, New England Journal of Medicine), Professor Jonathan Beckwith (American Cancer Society Professor of Microbiology and Molecular Genetics) and Professor Jonathan West (Associate Professor, Harvard Business School), writers received feedback on the content and strength of argument in their essays. Panelists were also asked to rate each essay, and, ultimately, a winning essay was chosen based on these rankings. The authors of the highest-ranking essay were given a subscription to the New England Journal of Medicine.
Kelley Larrow
Chair, Essay Contest Planning Committee
2002-2003 Health Policy Essay Competition
First Place
Incentive Misalignment and Conflict of Interest: The Greatest Challenge Facing the U.S. Healthcare System
Joshua Schimmer, MD Harvard Business School
And
Niteesh K. Choudry, MD, FRCPC Harvard Graduate School of Arts and Sciences
Runners-up
The Effect of Health and Prevention on Emergency Room Visits and Its Implication for Increasing Health Care Costs
Nivedita Uberoi Jerath
Harvard College
Establishing an Operation Model for Biotechnology Regulation
Chun-Ying Wu, MD, MPH, LLB
Harvard Law School
View the PDFs
Incentive Misalignment and Conflict of Interests
ER Visits and Health Care Costs.
Biotechnology Regulation
|
| 2004
Events Calendar |
|
This events calendar is compiled by the Harvard Health Caucus at Harvard Medical School. These events are not sponsored by the Caucus unless indicated. Please contact the Caucus if you would like to post your events.
Navigate through this calendar for scheduled events-indicated by a red circle
Place your cursor over the date for more information. If your browser does not support Java Applets, this information is also available below:
|
|
February
2004
Schedule of Events
| 2/11 |
6:00pm |
HARVARD
BUSINESS
SCHOOL
HEALTH
INDUSTRY
ALUMNI
ASSOCIATION
and
the
HARVARD
HEALTH
CAUCUS
AT
HARVARD
MEDICAL
SCHOOL
invite
you
to
attend
The
Significance
of
Vaccines
in
Global
Health
February
11th,
2004
Conference:
6:00
pm,
Reception
immediately
following.
Harvard
Business
School,
Spangler
Auditorium
Introduction
-
Vaccines:
Reexamining
the
Proven
Armamentarium
Wolfgang
Klietmann,
M.D.,
Lecturer
on
Pathology,
Harvard
Medical
School
Keynote
-
The
Significance
of
Vaccines
in
Global
Health
Raymond
V.
Gilmartin,
President
&
CEO,
Merck
&
Co.,
Inc.
Panel
Discussion
Raymond
V.
Gilmartin,
President
&
CEO,
Merck
&
Co.,
Inc.
Adel
Mahmoud,
M.D.,
Ph.D.,
President,
Merck
Vaccine
Division
Wolfgang
Klietmann,
M.D.,
MS,
Harvard
Business
School
Health
Industry
Alumni
Association
Moderator:
Raj
Shah,
M.D.,
Senior
Policy
Officer
and
Senior
Economist,
The
Bill
and
Melinda
Gates
Foundation
REGISTRATION
FOR
THIS
EVENT
IS
REQUIRED
and
will
be
available
in
January
from
this
HBS
Health
website.
www.hbshealth.org.
Click
on
"Events"
and
then
fill
out
registration
form.
The
Wall
Street
Journal
recently
identified
some
of
the
challenges
facing
the
vaccine
industry,
and
society:
The
malfunctioning
of
the
small
but
vital
marketplace
for
vaccines
in
America;
product
liability
lawsuits
impeding
vaccine
development
and
shrinking
profit
margins
have
driven
many
producers
out
of
this
indispensable
business;
and
the
government
exercise
of
monopsony
power
in
the
vaccine
market.
We
need
a
vital
vaccine
industry
in
collaboration
with
a
well
functioning
reorganized
Public
Health
System
to
contain
menacing
scourges
and
to
keep
contagion
in
check.
The
organizers
of
this
event
gratefully
acknowledge
the
support
of
Boston
Private
Bank.
|
|
|
|
|
|
|
|
Link to Event Archive
|
|
Links to Policy Roundtable 2002
Series
Discussions:
Keynote
Address: Jeffrey P. Koplan, Director of the Centers for Disease Control
13 February 2002
Healthier
or Wealthier: Which comes first in the new global era?
25 February 2002
The
Crisis of Neglected Diseases: Creating R&D Incentives for Diseases
of Developing Countries
28
February 2002
Health
Care Education in the Developing World: Bridging Global and Local Health Care Practices
07
March 2002
Building
a Legal Framework for Global Health: How can the US and UN work to reduce
global disparities?
20
Marchl 2002
Riding
East: The Global Tobacco Control Movement and the Role of the Mass Media
25 April 2002
PRS Meeting Materials
Introductory
Meeting Materials (19 September 2001)
PRS
Planning Materials
(from
the Operations Manual)
Note that these are all PDF
files.
Resources
for panel organizers.
Includes links to websites, papers, articles
that may be of use.
|